SCD and Hepatic steatosis: It was presented that genetic ablation of SCD1 in mice overexpressing AKT or/and neuroblastoma ras oncogene (NRas) did not inhibit lipogenesis and liver steatosis, nor did it affect the development of liver tumor, due to the upregulation of SCD2 [148].